French JD, Haugen BR, Worden FP, Bowles DW, et al. Combination Targeted Therapy with Lenvatinib and Pembrolizumab in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers. Clin Cancer Res 2024 Jun 26. doi: 10.1158/1078-0432.CCR-23-3417.
PMID: 38922338